Location History:
- New York, NY (US) (2017)
- New Yok, NY (US) (2023)
Company Filing History:
1 out of 2,896 
1 out of 560 
1 out of 512 
Years Active: 2017-2025
Title: Maurizio Scaltriti: Innovator in Cancer Therapy
Introduction
Maurizio Scaltriti is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer therapy. With a focus on developing targeted drug delivery systems and innovative treatment methods, he holds 3 patents that reflect his dedication to advancing medical science.
Latest Patents
Scaltriti's latest patents include groundbreaking work on PI3K inhibitors and their applications. One of his notable inventions involves the development of a new, targeted drug delivery paradigm that enhances the efficacy of PI3K inhibitors, particularly PI3Kα inhibitors. This advancement represents a significant leap in cancer therapy, providing compounds that are useful for treating various proliferative diseases, including cancer. Additionally, he has developed nanoparticles and nanogels that encapsulate these inhibitors for targeted delivery to cancer cells or tumors. Another important patent focuses on combination therapy using PDK1 and PI3K inhibitors, aimed at treating cancer cells that exhibit resistance to PI3K inhibition. This method involves administering a combination of inhibitors to effectively combat resistant cancer cells.
Career Highlights
Throughout his career, Maurizio Scaltriti has worked with esteemed institutions such as the General Hospital Corporation and Memorial Sloan Kettering Cancer Center. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research in cancer treatment.
Collaborations
Scaltriti has had the opportunity to work alongside notable colleagues, including Jose Baselga and Pau Castel. These collaborations have further enriched his research and innovation efforts in the realm of cancer therapy.
Conclusion
Maurizio Scaltriti's contributions to cancer therapy through his innovative patents and collaborations highlight his role as a key figure in the fight against cancer. His work continues to pave the way for new treatment options that can significantly improve patient outcomes.